Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development

Area of Science:

• Nanomedicine
• Materials Science
• Biotechnology

Background:

• Smart nanoparticles offer improved efficacy and reduced toxicity for cancer treatment.
• Surface functionalization of nanoparticles is key to enhancing their therapeutic properties.
• Cobalt oxide (CoO) nanoparticles are being explored for their potential anti-cancer applications.

Purpose of the Study:

• To evaluate the anti-cancer activity of phosphonomethyl iminodiacetic acid (PMIDA)-coated CoO nanoparticles.
• To assess the cellular uptake and apoptosis-inducing effects of PMIDA-Co nanoparticles on Jurkat and KB cancer cell lines.
• To compare the efficacy of PMIDA-Co nanoparticles with conventional anti-cancer drugs.

Main Methods:

• Synthesis of nano-sized CoO nanoparticles via thermal decomposition.
• Surface modification of CoO nanoparticles with PMIDA.
• Characterization using X-ray diffraction, dynamic light scattering, and transmission electron microscopy.
• Analysis of conjugation via Fourier transform infrared spectroscopy.
• Evaluation of cytotoxicity, cellular uptake, and apoptosis using flow cytometry and scanning electron microscopy.

Main Results:

• PMIDA-coated CoO nanoparticles were successfully synthesized with an average size below 100 nm.
• Enhanced cellular uptake of PMIDA-Co nanoparticles was observed in Jurkat and KB cell lines.
• Significant induction of apoptosis in cancer cells was facilitated by the PMIDA-coated nanoparticles.
• The observed effects were comparable to those of doxorubicin, a potent anti-cancer drug.

Conclusions:

• PMIDA-coated CoO nanoparticles demonstrate significant anti-cancer activity by enhancing cellular uptake and inducing apoptosis.
• These functionalized nanoparticles represent a promising smart drug delivery system for cancer therapy.
• Further research into PMIDA-Co nanoparticles could lead to more effective and less toxic cancer treatments.